Dr Reddys Laboratories launches Sirolimus Tablets

In strengths of 1 mg and 2 mg

Dr Reddys Laboratories announced the launch of Sirolimus Tablets, 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE (Sirolimus) tablets in the US market on 27 October 2014 following the approval of the United States Food & Drug Adminstration.

Dr Reddys Sirolimus Tablets, 1 mg and 2 mg are available in bottle counts of 100.

Powered by Capital Market - Live News